PRGO vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PRGO

33.9
AI Score
VS
PCRX Wins

PCRX

45.6
AI Score

Investment Advisor Scores

PRGO

34score
Recommendation
AVOID NEW MONEY

PCRX

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PRGO PCRX Winner
Forward P/E 7.3692 9.8912 PRGO
PEG Ratio 1.1418 0.9893 PCRX
Revenue Growth -5.2% -1.6% PCRX
Earnings Growth -63.6% 483.3% PCRX
Tradestie Score 33.9/100 45.6/100 PCRX
Profit Margin -43.3% 5.1% PCRX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD PCRX

Relative Price Performance (Last 90 Days)

PRGO 1M: +7.7% · 3M: +29.0% PCRX 1M: +0.4% · 3M: +57.3%

Current Technical Phase

PRGO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 61

RSI (14): 61.3 · Price: $16.55

PCRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.9% over 20 days), RSI 82

RSI (14): 81.6 · Price: $36.46

Fundamentals Snapshot

Metric PRGO PCRX
Market Cap — —
Forward P/E 7.2 10.5
Trailing P/E — 39.2
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin 0.0% 0.1%
EPS -12.47 0.93
Dividend Yield 0.07% —

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.